Latest Interviews
Showing 871–885 of 3,058 transcripts.
Clear all filters- Milken Institute1h 14m
Navigating a Changing Global Economy | Middle East and Africa Summit 2024
Laura Deal Lacey, Michael Milken, His Royal Highness Prince Turki Al Faisal Al Saud, Makhtar Diop, Mohamed Mansour, Alan Schwartz, Prince Turki Al Faisal Al Saud
Held in Abu Dhabi in December 2024, the 6th Annual Middle East and Africa Summit convened global leaders from the Milken Institute, the International Finance Corporation, and the Mansour Group to mobilize capital toward healthcare, economic development, and environmental sustainability. The event highlighted a strategic pivot where emerging markets are transforming from passive capital providers into technology hubs capable of bridging the gap between the aging Global North and Africa's young, growing workforce. Participants addressed critical investment barriers such as regulatory uncertainty and currency mismatches by proposing blended finance models and de-risking strategies to unlock trillions of dollars in private and philanthropic resources.
- Goldman Sachs20 min
Should investors worry about market concentration?
David Kostin, Owen Lamont, Alison Nathan
Strategists David Kostin and Owen Lamont converge on the projection that U.S. equity markets face a decade of sub-10% returns driven by extreme concentration and elevated valuations, though they diverge on whether the top ten stocks' dominance itself constitutes the primary risk. Kostin warns that the current 36% market cap concentration creates a negative equity risk premium and recommends shifting to equal-weighted indices, while Lamont argues that future volatility will stem from AI-driven creative destruction and mean reversion rather than portfolio structure. Both analysts acknowledge that the sustainability of the "magnificent seven's" growth and potential AI bubbles remain critical variables that could accelerate a decline in market performance over the next ten years.
- Milken Institute1h 1m
Decoding Disease: Can Genetics Unlock New Interventions? | Future of Health Summit 2024
Conor Hale, Colleen Campbell, Lon Cardon, Bernard Kwabi-Addo, Benjamin Neale
Experts highlight that while genomic knowledge has expanded to 12,000 identified variants, translating these discoveries into clinical care remains hindered by insurance barriers, provider literacy gaps, and biased data representation. To overcome these bottlenecks, the field is increasingly leveraging artificial intelligence for tumor heterogeneity analysis and shifting toward deconstructing common diseases into rare, monogenic subsets for targeted therapies. With sequencing costs dropping to roughly $200, stakeholders anticipate widespread population screening programs and systematic variant analysis across human diseases becoming feasible within the next decade.
- Milken Institute53 min
Health Care of the Future | Future of Health Summit 2024
Michael Milken, Alex Azar, Buddy Carter, Diana DeGette, Renee Wegrzyn
The event detailed how ARPA-H and legislative initiatives like "Cures 2.0" are addressing systemic healthcare challenges by funding high-risk biomedical innovations and ensuring pharmaceutical independence. Key figures including Rep. Diana DeGette and Rep. Chris Carter highlighted strategies to reform Medicare Advantage payment models and repatriate drug manufacturing to counter supply chain vulnerabilities. The panel concluded with a call for increased federal investment in translational science and a broader call for business leaders to enter government to sustain the pace of medical breakthroughs.
- Milken Institute1h 11m
Global Collaboration to Eradicate Women’s Cancers | Future of Health Summit 2024
Alice Park, Usman Malami Aliyu, Danielle Carnival, Dave Fredrickson, Roberta Lipson, Gemma Peters
Global cancer leaders convened to address the projected doubling of incidence in low- and middle-income countries by implementing diverse strategies ranging from Nigeria's mobile screening vans and mobile PCR labs in China to the UK's data-driven risk assessment partnerships. These initiatives prioritize overcoming structural inequities in treatment access, financial barriers, and clinical trial participation through innovations like AI-driven imaging, drug repurposing, and targeted care navigation programs. Ultimately, the consensus emphasizes that sustainable national cancer control plans must integrate geopolitical cooperation and equity-first designs to prevent the fragmentation of global research and ensure effective prevention for the most vulnerable populations.
- All-In Podcast8 min
DOGE's Opportunity: Unleash American Growth by Cutting Regulations
Chamath, Jason, Friedberg, Nick, J. Cal, Sachs, Freiburg
DOGE leaders Elon Musk and Chamath Palihapitiya propose a radical restructuring of the federal government by implementing a public performance leaderboard to expose inefficiencies and mandating automatic expiration dates for all regulations. They advocate for wiping the entire existing regulatory code to zero and replacing it with a simplified flat tax system, strategies projected to stimulate 4-5% GDP growth by eliminating bureaucratic redundancies. This approach shifts the federal operational model from regulatory expansion to deregulation, aiming to correct economic stagnation while holding public employees accountable for past excesses under a new incentive framework.
- Y Combinator33 min
How To Start A Dev Tools Company | Startup School
Drawing on Y Combinator's extensive portfolio of companies like GitLab and Stripe, this analysis outlines that successful DevTools founders must be technical builders who validate ideas through rapid prototyping and direct developer engagement. The presentation emphasizes a bottom-up sales strategy where founders personally sell to technical buyers, prioritizing usage-based monetization and open-source trust-building over traditional marketing. Furthermore, it identifies key pitfalls such as premature hiring and non-technical leadership, advocating instead for a founder-led approach until the product reaches approximately $1 million in annual recurring revenue.
- Milken Institute58 min
Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024
Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels
This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.
- a16z10 min
Disrupt Yourself
The speaker frames the current transition in life sciences as an industrial revolution where biology shifts from artisanal discovery to engineered automation, urging leaders to proactively disrupt themselves before market forces do. Drawing parallels to strategic pivots by Jensen Huang at Nvidia and Steve Jobs with AT&T, the presentation defines corporate survival as a form of social engineering that prioritizes future ecosystems over existing profitability. Ultimately, the event calls for redefining healthcare and entertainment as technology sectors to fundamentally reshape illness prevention and treatment.
- All-In Podcast1h 10m
DOGE unveils a roadmap, Unlocking GDP Growth, WW3 escalation, Fat cell memory
Chamath, Friedberg, Jason Calacanis, David Sacks
Elon Musk and Vivek Ramaswamy's Department of Government Efficiency plans to eliminate $500 billion in unauthorized federal spending over an 18-month period by leveraging recent Supreme Court rulings to bypass traditional legislative approval processes. The initiative targets regulatory rollbacks through executive audits and temporary payment suspensions while facing anticipated legal challenges from entrenched bureaucratic interests and internal Republican resistance to deficit reduction. Concurrently, the discussion highlights global security risks regarding Western missile capabilities in the Ukraine-Russia conflict and presents scientific breakthroughs in epigenetics that explain persistent obesity mechanisms despite weight loss.
- Milken Institute1h 0m
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.
- Goldman Sachs33 min
Primavera Capital’s Fred Hu on China’s economic trajectory
Following a historic equity rally triggered by unprecedented joint policy directives from China's financial regulators and top leadership, Fred Hu of Primavera Capital Group characterizes the current market upturn as a normalization phase with substantial catch-up potential. Hu anticipates that near-term fiscal stimulus will target household consumption while arguing that long-term confidence depends on structural reforms that reassure the private sector and accelerate innovation in fields where China currently lags in generative AI. Beyond immediate market dynamics, the event highlights China's undisputed leadership in green energy and a massive demographic opportunity within its 800 million-person middle class, which analysts project will soon drive private consumption to become the primary engine of national GDP growth.
- Milken Institute54 min
Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024
Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun
As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.
- Y Combinator23 min
Twitter vs. X: Product Lessons For Startup Founders
The presentation critiques the trend of optimizing social platforms for singular engagement metrics, arguing that this strategy degrades user satisfaction by creating "engagement farms" filled with low-quality content. Using Twitter's transformation under Elon Musk as a primary case study, the analysis highlights how shifting from a chronological feed to an algorithmic model has diluted content quality, confused verification systems, and likely reduced advertising revenue despite boosting raw usage time. Ultimately, the speaker advises product leaders to define clear "good states" for users and resist growth-at-all-costs pressures to ensure long-term retention and genuine value.
- Milken Institute40 min
Bot or Not?: AI in Health Care | Future of Health Summit 2024
Richard Lui, Dipanwita Das, John Halamka, Vidya Raman-Tangella
Industry leaders including Sociero CEO Dipanita Das, Mayo Clinic President Dr. John Halamka, and Teladoc CMO Vidya Rahman convened to argue that while technical barriers to healthcare AI have dissolved, cultural resistance and data heterogeneity now impede transformative progress. The panel highlighted critical successes such as Mayo Clinic's ability to detect Stage Zero pancreatic cancer and Teladoc's use of generative AI for personalized patient engagement, underscoring the necessity of embedding real-world evidence and clinical validation into care pathways. Ultimately, the group urged a strategic shift from adopting technology for novelty to solving specific operational problems, calling for a global federated data network to achieve a preventative "precision health" vision for four billion people by 2030.